{"product_id":"mounjaro-tirzepatida-frasco-ampolleta-5mg-0-5-ml-con-1-dosis-unica","title":"Mounjaro (Tirzepatide) Vial 2.5mg\/0.5ml With 1 Single Dose","description":"\u003ch2\u003eCategory\u003c\/h2\u003e\n\u003cp\u003eMedicine\u003c\/p\u003e\n\n\u003ch2\u003eLine\u003c\/h2\u003e\n\u003cp\u003eAntidiabetics\u003c\/p\u003e\n\n\u003ch2\u003eBrand\u003c\/h2\u003e\n\u003cp\u003eMounjaro\u003c\/p\u003e\n\n\u003ch2\u003eMolecule\u003c\/h2\u003e\n\u003cp\u003eTirzepatide\u003c\/p\u003e\n\n\u003ch2\u003ePresentation\u003c\/h2\u003e\n\u003cp\u003eVial 5Mg\/0.5 Ml With 1 Single Dose\u003c\/p\u003e\n\n\u003ch2\u003eLaboratory\u003c\/h2\u003e\n\u003cp\u003eLilly\u003c\/p\u003e\n\n\u003ch2\u003eIndications\u003c\/h2\u003e\n\u003cp\u003eMounjaro (Tirzepatide) is indicated for the treatment of type 2 diabetes in adults. This medication is used in combination with an appropriate diet and exercise to improve glycemic control in patients who have not achieved their glycemic control goals with other antidiabetic medications. Tirzepatide acts as a GLP-1 receptor agonist and also has actions on the GIP receptor, which contributes to glucose regulation and weight reduction. Regular monitoring of blood glucose levels is recommended and therapy should be adjusted as needed.\u003c\/p\u003e\n\n\u003ch2\u003eComposition\u003c\/h2\u003e\n\u003cp\u003eEach ampoule contains: 5 mg of Tirzepatide, excipients necessary for the formulation of the product.\u003c\/p\u003e\n\n\u003ch2\u003eContraindications\u003c\/h2\u003e\n\u003cp\u003eMounjaro is contraindicated in patients with a history of hypersensitivity to tirzepatide or any of the excipients in the formulation. It should not be used in patients with type 1 diabetes or diabetic ketoacidosis. Caution should be exercised in patients with a history of pancreatitis or gastrointestinal diseases.\u003c\/p\u003e\n\n\u003ch2\u003ePrecautions\u003c\/h2\u003e\n\u003cp\u003eRenal function evaluation is recommended before starting treatment with Mounjaro. It should be used with caution in patients with a history of cardiovascular diseases. It is suggested not to use in combination with other GLP-1 agonists or insulin. It is important to inform the patient about the signs and symptoms of pancreatitis and the need to seek medical attention if they occur.\u003c\/p\u003e\n\n\u003ch2\u003eStorage\u003c\/h2\u003e\n\u003cp\u003eStore in a refrigerator between 2°C and 8°C. Do not freeze. Keep the vial in its original packaging to protect it from light. Once opened, it can be used according to the doctor's instructions.\u003c\/p\u003e\n\n\u003cp\u003eConsult your doctor.\u003c\/p\u003e\n\n\u003cp\u003ePrescription required.\u003c\/p\u003e","brand":"Lilly","offers":[{"title":"Default Title","offer_id":46414195589345,"sku":"7501082243635","price":2012.4,"currency_code":"MXN","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0722\/1500\/3361\/files\/mounjaro_tirzepatida_frasco_ampolleta_5mg_0_5_ml_con_1_dosis_unica_7501082243635_1.jpg?v=1779150509","url":"https:\/\/wecarepharma.mx\/en\/products\/mounjaro-tirzepatida-frasco-ampolleta-5mg-0-5-ml-con-1-dosis-unica","provider":"WeCare Pharma","version":"1.0","type":"link"}